Consultant Clinical Oncologist (Thyroid, Head & Neck)

Job Reference: 361-R2R-1656-CON

Salary: £79,860 - £107,668

Location: Hertford, United Kingdom

Speciality: Oncology

Applications are invited for a Consultant in Clinical Oncology with a special interest in Thyroid and Head & Neck Malignancies, based at the Mount Vernon Cancer Centre in Northwood, Middlesex. This is a substantive post and comprises 10 programmed activities (PAs) and an on-call commitment.

Please note that the JD is subject to approval by the Royal College

This is an excellent opportunity within the Oncology department at East and North Hertfordshire NHS Trust. Applications are invited for this re-organised post available immediately to provide site specific services to the local population and surrounding areas. Out-patient duties will be at the Luton, Northwick Park Hospital and Wexham Park Hospital, with radiotherapy activity and complex SACT delivered at Mount Vernon Cancer Centre. The post holder will specialise in the management of thyroid and head and neck malignancies, joining a dynamic team of surgeons and oncologists with a significant national research reputation. The post holder would be expected to have a strong interest in technical radiotherapy and in the further development of complex radiotherapy services

Mount Vernon Cancer Centre is the largest single site cancer centre in the south of England, with 22 clinical oncologists, 6 medical oncologists, 4 cancer radiologists and 1 palliative care physician, serving 15 surrounding hospitals.

Mount Vernon Cancer Centre is a stand-alone centre. There are 22 in-patient beds which provide specialist oncology care to patients requiring in-patient support. We have an ambulatory care unit open 8 to 8, which provides support for acute oncology patients and day case supportive treatment. Specialist medical and surgical care is provided by SLAs with Hillingdon Hospital as the estate landlord, and surrounding DGH’s as required.

The Cancer Centre currently has 7 Linear accelerators (including 4 TrueBEAM machines capable of delivering rapid arc therapy) and two CT simulators. Development plans include the commissioning of MRI planning. The first Cyberknife facility in the NHS in the UK was established at Mount Vernon, which has been clinically active since 2010. The post holder would be expected to continue the further development of stereotactic radiotherapy and the delivery of SABR Lung treatments.

The Mount Vernon Head and Neck Cancer department receives in the region of 450 – 500 new referrals (250 – 300 radiotherapy, 50 – 60 palliative systemic treatment, 100 – 120 thyroid cancer) annually, thereby making it one of the busiest Head and Neck departments in the UK. Referrals are received from North West London, Hertfordshire, South Bedfordshire, South Buckinghamshire, and East Berkshire. Patients are discussed in 2 SMDTs (Northwick Park/Wexham Hospitals, and Luton/Lister Hospitals). The sheer number of patients provides exciting opportunities for clinical as well as research development.

The Mount Vernon head and neck oncology team comprises 3 clinical oncologists, 2 trainee registrars, 2 clinical nurse specialists (CNS), 2 radiotherapy support nurses, 3 dieticians and 2 speech & language therapists. The department adopts a team-based approach with the clinical workload. Although each oncologist has a direct clinical relationship with specific ENT or OMFS team of different hospitals, all 3 oncologists join in the 2 S-MDTs, and patients are referred centrally to Mount Vernon Cancer Centre for oncological opinion. There are 2 consultant oncologists in each head neck clinic to ensure valuable clinical discussion and to provide cross cover. Each consultant does a monthly visit to their allied district general hospitals for MDTs and the joint oncology-surgical clinics.

Patients on treatment are reviewed by the clinicians/registrars or the CNS, supported by the AHPs. Patients going through palliative systemic treatment (chemotherapy or immunotherapy) are also reviewed by a clinical pharmacist. There is a weekly multi-professional head and neck meeting to ensure effective communications and handover in patient care.

Radiotherapy planning is done according to local network guidance. Radiotherapy volume peer review, as recommended by the Royal College of Radiologists, is mandatory at Mount Vernon. The peer review meeting is also attended by a head and neck radiologist. This peer review process will reduce inter-observer/treatment variation and ensure robust future analyses of patients’ oncologic outcomes. There is a regular 3-monthly head and neck radiotherapy quality-improvement meeting with physics to ensure progressive development.

Mount Vernon Cancer Centre delivers around 200 doses of radioactive iodine per year. There are two radioactive iodine treatment rooms and new thyroid referrals are seen at Mount Vernon. Referrals for thyrotoxicosis are seen in group consultations at the centre with strong support from the Nuclear Medicine Department. A new SPECT scanner has recently been installed providing many more opportunities for developing the service.

Research opportunities are excellent within the cancer centre. All head and neck oncologists are keenly encouraged to develop innovative clinical research activity.

Applicants must be on the Specialist Register, or be within 6 months of doing so, at the time of interview. Applications from those wishing to work part-time or job share are welcomed.

It is imperative that you also attach your CV to your application as this is an integral part of the application process. Dependent on the number of applications, we may not contact you if you fail to do so. Please ensure to supply the names and addresses of referees. This must cover a period of 3 years with no gaps, one of whom must be your current employer.

For further details / informal visits contact:

Mrs Jagdeep Kudhail, Divisional Chair, Cancer Services
Email address: [email protected]
Telephone number 0203 826 2655



Apply Here